ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Debt / NOTE 1.000% 9/1
Principal, excl. options Q3 2024
904M
Holdings value Q3 2024
$1.06B
Value change Q3 2024
+$162M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
57
Number of buys Q3 2024
23
Number of sells Q3 2024
-37
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $904M $1.06B +$162M $1.17 57
2024 Q2 $743M $804M -$143M $1.08 63
2024 Q1 $885M $835M +$37.6M $0.94 67
2023 Q4 $852M $845M +$21.2M $0.99 65
2023 Q3 $847M $790M +$790M $0.93 54